The forum brings together leaders in IO to discuss the current market, facilitating multiple new and renewed interactions among the participants.

Lumanity will be chairing two panels at the forum:

New Endpoints for Early-Stage Oncology Companies Panel
Chaired by:
– Jeffrey Bockman, EVP Expert Advisor, Oncology, Lumanity Head, Oncology Center of Excellence, Lumanity
– Colette Lipp, Director, Global BD Oncology & Immuno-Oncology, Merck KGaA, Darmstadt, Germany
– James Barlow, President & CEO, ImmunoGenesis Inc.
– Matthew Price, Co-Founder, EVP & Chief Operating Officer, Promontory Therapeutics Inc.
– Nadim Ahmed, President & CEO, Cullinan Oncology, Inc.
– Raven Lin, Co-Founder & CEO, Pilatus Biosciences SA

Advanced Immunotherapies Panel: Cell Therapies & Cancer Vaccines
Chaired by:
– Michael Rice, Expert Advisor, SVP, Cell & Gene Therapy, Lumanity
– Kaveri Pohlman, Director, Biotechnology Equity Research, BTIG, LLC
– Deborah Rathjen, Managing Director & CEO, Carina Biotech
– Sath Nirmalananthan, CFO, Scancell
– Niranjan Sardesai, Founder, President & CEO, Geneos Therapeutics, Inc.
– Polly Brown, VP Head of Business Development, Oncology R&D, AstraZeneca
– Upendra Marathi, President & CEO, 7 Hills Pharma Inc

Connect with our staff or schedule a time to meet during the meeting by reaching out to